Liothyronine Sodium

Product NDC
68151-0237
11-digit product format
681510237
Labeler code
68151
Product ID
68151-0237_efcddc0e-454b-45e3-b78c-1e9f5a2cdb8a
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
Liothyronine Sodium
Dosage form
TABLET
Route
ORAL
Labeler
Carilion Materials Management
Application
ANDA090097
Marketing category
ANDA
Marketing start
2009-03-23
Marketing end
0000-00-00
Substance
LIOTHYRONINE SODIUM
Active strength
5 ug/1
Pharmacologic classes
l-Triiodothyronine [EPC],Triiodothyronine [CS]
NDC exclude flag
E
Listing certified through
2018-12-31
Current FDA listing
Historical FDA.report record

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
b42496cd-a994-8ba1-597f-e507aa62246eProduct name520250116

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
68151-0237-02020-01-31C16284748780-19d75b9d1-22a7-f424-e053-dadaa90a57ceLiothyronine Sodium Tablets, USP

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
68151-0237-0Liothyronine Sodium1 in 1 PACKAGETABLET12

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
68151-0237LIOTHYRONINE SODIUM TABLET [CARILION MATERIALS MANAGEMENT]2Legacy NDC, 1 package rows20140707_bc225ead-22b5-444e-9254-01c6250a1175.zip

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYDailyMedSPL version
903456liothyronine sodium 5 MCG Oral TabletPSNbc225ead-22b5-444e-9254-01c6250a11752
903456liothyronine sodium 0.005 MG Oral TabletSCDbc225ead-22b5-444e-9254-01c6250a11752
903456liothyronine sodium 5 MCG Oral TabletSYbc225ead-22b5-444e-9254-01c6250a11752

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionStatus
68151-0237-0681510237001 in 1 PACKAGEHistorical